| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444622 | European Journal of Cancer | 2013 | 12 Pages |
Abstract
These findings highlight the role of syndecan-1 as a potential therapeutic target in melanoma and ovarian carcinoma and provide a new tool able to block vessel maturation, one of the mechanisms that underpin the angiogenic process essential for solid tumour growth.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Paola Orecchia, Romana Conte, Enrica Balza, Andrea Petretto, PierLuigi Mauri, Maria Cristina Mingari, Barbara Carnemolla,